Stephane is a biotech entrepreneur with 25 years experience in developing biotechs and innovative treatments. He graduated in Finance (ESCP Europe in Paris), worket at Sanofi in finance. After a strategy consulting position at OC&C, he co-founded in 2003 and was CFO of Endotis Pharma. He co-founded and was CEO of the immuno-oncology Gamamabs Pharma, until the sale of its key asset to Exelixis in 2021.
Speaking In
3:30 PM - 3:45 PM
Monday, June 5
